Short Interest in Halberd Co. (OTCMKTS:HALB) Expands By ?

Halberd Co. (OTCMKTS:HALB) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 62,846 shares, a growth of ? from the August 15th total of 0 shares. Based on an average trading volume of 355,993 shares, the short-interest ratio is currently 0.2 days.

Halberd Stock Performance

OTCMKTS:HALB remained flat at $0.00 during trading hours on Wednesday. Halberd has a one year low of $0.00 and a one year high of $0.00.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.